In a breakthrough cancer therapy development, scientists at MIT and Harvard Medical School created a new way of designing ...
The deal expands Bristol Myers Squibb's CAR T-cell immunotherapy portfolio with Orbital's lead experimental candidate, ...
MIT and Harvard scientists have created engineered CAR-NK cells that can hide from the immune system and more effectively ...
Johns Hopkins scientists discovered a way to convert “immune-cold” tumors into “immune-hot” ones by activating key immune ...
The Brighterside of News on MSN
Scientists re-engineer a patient’s own T cells to target and destroy cancer cells
Hodgkin lymphoma and other malignancies that express the CD30 protein have been the scourge of oncologists for decades. For ...
11 天on MSN
Protein engineering toolset boosts efficacy of CAR-T cells targeting blood and solid cancers
Cancer researchers focused on improving the success of cancer immunotherapies introduced a new tool in a Yale study published ...
The award named after German businessman Bernard Broermann, recognizes outstanding scientific achievements in the field of ...
The aim of immunotherapy strategies is to leverage cells in the patient's own immune system to destroy tumor cells. Using a ...
Scientists discovered that inhibiting the enzyme STK17B forces multiple myeloma cells into iron-driven death and makes ...
7 天on MSN
Inspired by Her Beloved Grandma's Health Journey, a Stem Cell Nurse Saves the Life of a ...
Emily Coiro is a stem cell nurse in New Jersey. After seeing her grandmother struggle with blood cancer, she decided to ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果